Lori D. Dwyer‐Nield

2.9k citations

60 papers · 2.4k indexed · h-index 27

Molecular Biology top 5%
Immunology top 5%
Oncology top 5%
Pulmonary and Respiratory Medicine top 5%
Cancer Research top 5%

Co-authors: Alvin M. Malkinson Alison K. Bauer Rajesh Agarwal Elizabeth F. Redente Pamela L. Rice Robert L. Keith Rana P. Singh David Dinsdale
Topics: RNA modifications and cancer (10 papers)Inflammatory mediators and NSAID effects (9 papers)Cancer-related molecular mechanisms research (6 papers)
Cited by: Cancer Research Immunology Molecular Biology
Journals: PLoS ONE JNCI Journal of the National Cancer Institute Cancer Research
Partner nations: United States India United Kingdom

In The Last Decade

Lori D. Dwyer‐Nield

60 papers receiving 2.3k citations

Peers

Countries citing papers authored by Lori D. Dwyer‐Nield

Since Specialization

Citations

This map shows the geographic impact of Lori D. Dwyer‐Nield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori D. Dwyer‐Nield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori D. Dwyer‐Nield more than expected).

Fields of papers citing papers by Lori D. Dwyer‐Nield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori D. Dwyer‐Nield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori D. Dwyer‐Nield. The network helps show where Lori D. Dwyer‐Nield may publish in the future.

Co-authorship network of co-authors of Lori D. Dwyer‐Nield

This figure shows the co-authorship network connecting the top 25 collaborators of Lori D. Dwyer‐Nield. A scholar is included among the top collaborators of Lori D. Dwyer‐Nield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori D. Dwyer‐Nield. Lori D. Dwyer‐Nield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers 2019 ·Cancer Prevention Research ·Robert L. Keith,Patrick J. Blatchford,Daniel T. Merrick,Paul A. Bunn,(unknown),Lori D. Dwyer‐Nield,(unknown),Mark W. Geraci,York E. Miller	19
2	The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model 2017 ·Cancer Prevention Research ·Lori D. Dwyer‐Nield,Gregory A. Hickey,(unknown),Kevin S. Choo,Debbie G. McArthur,Meredith A. Tennis,(unknown),Mark W. Geraci,Robert L. Keith	8
3	Silibinin modulates TNF‐α and IFN‐γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells 2011 ·Molecular Carcinogenesis ·Alpna Tyagi,Chapla Agarwal,Lori D. Dwyer‐Nield,Rana P. Singh,Alvin M. Malkinson,Rajesh Agarwal	53
4	The Kras Mutational Spectra of Chemically Induced Lung Tumors in Different Inbred Mice Mimics the Spectra of KRAS Mutations in Adenocarcinomas in Smokers versus Nonsmokers 2010 ·Journal of Thoracic Oncology ·Jason M. Fritz,Lori D. Dwyer‐Nield,(unknown),Alvin M. Malkinson	12
5	Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization 2010 ·American Journal Of Pathology ·Elizabeth F. Redente,Lori D. Dwyer‐Nield,(unknown),Komal Raina,Rajesh Agarwal,William Pao,Pamela L. Rice,Kenneth R. Shroyer,Alvin M. Malkinson	76
6	Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells 2010 ·Experimental Lung Research ·Pamela L. Rice,Bradley S. Barrett,Jason M. Fritz,(unknown),Lori R. Kisley,Alvin M. Malkinson,Lori D. Dwyer‐Nield	7
7	Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3 2009 ·Cancer Prevention Research ·Alpna Tyagi,Rana P. Singh,Kumaraguruparan Ramasamy,Komal Raina,Elizabeth F. Redente,Lori D. Dwyer‐Nield,Richard A. Radcliffe,Alvin M. Malkinson,Rajesh Agarwal	95
8	Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice. 2009 ·PubMed ·Elizabeth F. Redente,Lori D. Dwyer‐Nield,Bradley S. Barrett,David W. H. Riches,Alvin M. Malkinson	14
9	Epistatic interactions govern chemically‐induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J‐ChrA/J chromosome substitution strains 2009 ·International Journal of Cancer ·Lori D. Dwyer‐Nield,Jay McQuillan,(unknown),Richard A. Radcliffe,Ming You,Joseph H. Nadeau,Alvin M. Malkinson	17
10	A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment 2008 ·Cancer Research ·Robert S. Stearman,Lori D. Dwyer‐Nield,Michael C. Grady,Alvin M. Malkinson,Mark W. Geraci	38
11	Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice 2007 ·Cancer Chemotherapy and Pharmacology ·Laura K. Zerbe,Lori D. Dwyer‐Nield,Jason M. Fritz,Elizabeth F. Redente,(unknown),(unknown),(unknown),Chris Tucker,S. Gail Eckhardt,Daniel L. Gustafson,Kenneth K. Iwata,Alvin M. Malkinson	30
12	Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A₂null mice 2006 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Amy M. Meyer,Lori D. Dwyer‐Nield,Gregory J. Hurteau,Robert L. Keith,Yanli Ouyang,Brian M. Freed,Lori R. Kisley,Mark W. Geraci,Joseph V. Bonventre,Raphael A. Nemenoff,Alvin M. Malkinson	11
13	Quantitative analysis of early chemically-induced pulmonary lesions in mice of varying susceptibilities to lung tumorigenesis 2005 ·Cancer Letters ·(unknown),Laura K. Zerbe,Lori D. Dwyer‐Nield,Lori R. Kisley,Alvin M. Malkinson	36
14	Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines 2005 ·Carcinogenesis ·Lori D. Dwyer‐Nield,(unknown),Bradley S. Barrett,Jin‐Hee Ahn,Pippa F. Cosper,Amy M. Meyer,Lori R. Kisley,Alison K. Bauer,David C. Thompson,Alvin M. Malkinson	22
15	Morphological Assessment of Apoptosis in Human Lung Cells 2003 ·Lung Cancer ·Lori D. Dwyer‐Nield,David Dinsdale,John Cohen,Margaret Squier,Alvin M. Malkinson	3
16	Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion 2001 ·Toxicology ·John A. Thompson,Timothy J. Carlson,(unknown),Lori D. Dwyer‐Nield,Alvin M. Malkinson	27
17	The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice 2001 ·Toxicology ·Alison K. Bauer,Lori D. Dwyer‐Nield,Joseph A. Hankin,Robert C. Murphy,Alvin M. Malkinson	87
18	Growth inhibition in G1 and altered expression of cyclin D1 and p27kip-1after forced connexin expression in lung and liver carcinoma cells 2000 ·Journal of Cellular Biochemistry ·(unknown),(unknown),(unknown),(unknown),David C. Thompson,Lori D. Dwyer‐Nield,Pamela L. Rice,(unknown),Alvin M. Malkinson,Randall J. Ruch	72
19	Mouse lung epithelial cell lines—tools for the study of differentiation and the neoplastic phenotype 1997 ·Toxicology ·Alvin M. Malkinson,Lori D. Dwyer‐Nield,Pamela L. Rice,David Dinsdale	115
20	Very early changes in pulmonary protein kinase C-α and calpain II contents following injection of butylated hydroxytoluene (BHT) into mice 1995 ·Toxicology ·(unknown),Lori D. Dwyer‐Nield,Alvin M. Malkinson	5

About Lori D. Dwyer‐Nield

Lori D. Dwyer‐Nield is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 60 papers that have together received 2.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Inflammatory mediators and NSAID effects (9 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (458 citations), Immunology (496 citations) and Molecular Biology (1.3k citations). Lori D. Dwyer‐Nield has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Alvin M. Malkinson, Alison K. Bauer, Rajesh Agarwal, Elizabeth F. Redente, Pamela L. Rice, Robert L. Keith, Rana P. Singh, David Dinsdale, Mark W. Geraci and Laura K. Zerbe. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact